Trials / Completed
CompletedNCT04891666
A Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Children
A Clinical Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 (SmartGuard®) on Blood Lead Levels in Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Novozymes A/S · Industry
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The study is a parallel, randomized, double-blind, placebo controlled clinical trial will evaluate the effect of Lactobacillus plantarum DSM 33464 on reduction of Blood lead levels and general well-being of children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactobacillus plantarum DSM 33464 | 1 sachet SmartGuard® per day for 12 weeks |
| DIETARY_SUPPLEMENT | Placebo | 1 sachet of placebo per day for 12 weeks |
Timeline
- Start date
- 2021-07-06
- Primary completion
- 2023-03-17
- Completion
- 2023-03-17
- First posted
- 2021-05-18
- Last updated
- 2023-07-14
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04891666. Inclusion in this directory is not an endorsement.